ARCHIVES

Two Phase II Trials Display Ramucirumab Potential Efficacy

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Recurrent Low-Grade Serous Carcinoma Less Responsive To Chemotherapy

March 28, 2008

Henschke: I-ELCAP Plans to Enroll 100,000 Patients In Controversial Screening Trial

June 24, 2011

American Health Fdn. Honors NCI On Act’s 20th Anniversary

December 13, 1991

Blood Cancers Advocacy Groups Seek DOD And NCI Funds, Medicare Coverage.

July 6, 2001

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000

AACR Selects Eight Finalists To Compete For $15 Million Grants Funded By Telethon.

December 5, 2008